p53RFP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of p53RFP monoclonal antibodies for various research applications. p53RFP Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). p53RFP plays a critical role in regulating the cell cycle and maintaining genomic stability, acting as a tumor suppressor that prevents the proliferation of cells with damaged DNA. The significance of p53RFP in cancer research is substantial, as mutations in the p53 gene are commonly associated with various types of tumors. Understanding the function and regulation of p53RFP is essential for developing targeted therapies and improving cancer treatment outcomes. Researchers worldwide utilize p53RFP monoclonal antibodies to advance their studies in cellular pathways and cancer biology. p53RFP monoclonal antibodies enable precise detection and analysis of protein expression patterns across different experimental conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to uncover new insights in cancer biology and contribute to the development of innovative therapeutic strategies.